Cure8 research brief
FAP appears linked to both inflammation and fibrosis in IBD; distinguishing cellular versus extracellular FAP might help develop or validate fibrosis biomarkers that detect fibrostenotic disease.
Researchers studying IBD fibrosis or biomarkers; clinicians interested in fibrosis diagnostics for Crohn's disease and refractory ulcerative colitis; translational scientists working on anti‑fibrotic targets.
The researchers combined qPCR, immunohistochemistry, and imaging mass cytometry on resection specimens and cultured primary intestinal fibroblasts to map where FAP is expressed. Total FAP protein was highest in fibrostenotic disease, but cellular FAP was concentrated in CD90+ stromal cells from inflamed areas.
In vitro fibroblast cultures deposited matrix containing extracellular FAP, supporting the tissue findings. These results support FAP as a candidate fibrosis‑related biomarker in IBD and suggest that measuring total versus cellular/extracellular FAP could reflect different tissue states (inflammation vs established fibrosis).
However, this is an observational tissue study and does not test clinical outcomes or treatments.
The classification and conclusions are drawn from the article abstract and reported methods (qPCR, IHC, imaging mass cytometry, and fibroblast cultures). This is tissue‑based research and does not report clinical trial results or validated clinical tests.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Early clinical data suggest PALI-2108 may affect both inflammation and fibrosis in Crohn’s disease and shows biomarker changes (like fecal calprotectin) that could matter to people monitoring disease activity.
Fibrosis and stricturing are key problems in Crohn’s disease with limited therapies; this study identifies a microbiota–bile acid–GPBAR1 pathway by which a specific probiotic mix reduced inflammation and fibrosis in...
New PET tracers like FAPI could better detect fibrosis and stromal activity than standard FDG-PET, which may improve imaging of fibrostenotic Crohn's disease. For people with IBD, improved imaging might eventually help...
